- Home
- AXIL vs PLUR Comparison
AXIL vs PLUR Comparison
Compare AXIL & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXIL
- PLUR
- Stock Information
- Founded
- AXIL 2015
- PLUR 2001
- Country
- AXIL United States
- PLUR Israel
- Employees
- AXIL N/A
- PLUR N/A
- Industry
- AXIL Package Goods/Cosmetics
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXIL Consumer Discretionary
- PLUR Health Care
- Exchange
- AXIL Nasdaq
- PLUR Nasdaq
- Market Cap
- AXIL 36.8M
- PLUR 37.6M
- IPO Year
- AXIL N/A
- PLUR N/A
- Fundamental
- Price
- AXIL $5.49
- PLUR $4.41
- Analyst Decision
- AXIL
- PLUR Strong Buy
- Analyst Count
- AXIL 0
- PLUR 1
- Target Price
- AXIL N/A
- PLUR $12.00
- AVG Volume (30 Days)
- AXIL 17.2K
- PLUR 9.3K
- Earning Date
- AXIL 10-07-2025
- PLUR 11-11-2025
- Dividend Yield
- AXIL N/A
- PLUR N/A
- EPS Growth
- AXIL N/A
- PLUR N/A
- EPS
- AXIL 0.15
- PLUR N/A
- Revenue
- AXIL $27,262,468.00
- PLUR $1,336,000.00
- Revenue This Year
- AXIL N/A
- PLUR $246.11
- Revenue Next Year
- AXIL N/A
- PLUR $169.62
- P/E Ratio
- AXIL $40.36
- PLUR N/A
- Revenue Growth
- AXIL 0.07
- PLUR 309.82
- 52 Week Low
- AXIL $3.54
- PLUR $3.33
- 52 Week High
- AXIL $10.75
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- AXIL 41.45
- PLUR 42.92
- Support Level
- AXIL $5.53
- PLUR $4.08
- Resistance Level
- AXIL $6.26
- PLUR $4.50
- Average True Range (ATR)
- AXIL 0.57
- PLUR 0.21
- MACD
- AXIL -0.06
- PLUR -0.03
- Stochastic Oscillator
- AXIL 9.60
- PLUR 47.11
About AXIL AXIL Brands Inc. Common Stock
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.